Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Modular PMA policy tied to user fee shortfall: CDRH's decision to exempt modular PMAs from user fees if the first module was submitted prior to Oct. 1, 2002 resulted in higher PMA costs for fiscal 2004, Director David Feigal tells attendees during the Regulatory Affairs Professionals Society's annual meeting in Baltimore Oct. 19-22. "Had we made the opposite decision on modular 510(k)s, we would have hit the [FY 2003] fees right on the nose," he notes. "One of the reasons we didn't raise $25 mil. and only raised $19 mil. [is that we had] 54 PMAs last year and there were also 22 modular PMAs in house." Standard PMA fees for FY 2004 will increase almost 35% to $206,811 (1"The Gray Sheet" Aug. 4, 2003, p. 3)...
You may also be interested in...
CBER Should Retain Jurisdiction of Assigned Device Reviews – HHS Report
Improved device review times, including speedy handling of West Nile Virus diagnostics, convinced HHS that the Center for Biologics Evaluation & Research should retain jurisdiction over blood and tissue-related devices already assigned to the center
CBER Should Retain Jurisdiction of Assigned Device Reviews – HHS Report
Improved device review times, including speedy handling of West Nile Virus diagnostics, convinced HHS that the Center for Biologics Evaluation & Research should retain jurisdiction over blood and tissue-related devices already assigned to the center
AdvaMed Seeks Additions To MDUFMA Reuse Lists, Criticizes Review Criteria
The Association of Medical Device Reprocessors will meet with FDA Sep. 12 to discuss the agency's validation guidance, according to AMDR reps